跳至主要内容
临床试验/CTRI/2022/07/044079
CTRI/2022/07/044079尚未招募未知

A Comparative Study Of Efficacy And Safety Of Bimatoprost And Timolol In Patients With Primary Open Angle Glaucoma.

Dr Sreyanwita Mukherjee0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age: 18 to 60 years of age of either sex.
  • Patients with newly diagnosed, drug naive, primary open angle glaucoma patients of either sex attending the Department of Ophthalmology OPD at College of Medicine & Sagore Dutta Hospital, Kamarhati, Kolkata.
  • Patient who will give the written informed consent form voluntarily and are available during the entire study duration.

排除标准

  • Pregnant or lactating women.
  • Patients who are suffering from other congenital glaucoma secondary to other ophthalmic conditions.
  • Patient who has undergone any kind of medical and surgical treatment in the past.
  • Patient who has undergone corrective refractive surgery.
  • Patients with uncontrolled Hypertension, Diabetes mellitus.
  • Patients receiving chemotherapy for Malignancy.
  • Patients having infection in one or both eyes within the last three months.
  • Patients having ocular injury within last three months.
  • Patients suffering from major systemic illness or features of severe systemic infection are excluded from the study.

研究者

发起方
Dr Sreyanwita Mukherjee

相似试验